IN2014MN01806A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01806A IN2014MN01806A IN1806MUN2014A IN2014MN01806A IN 2014MN01806 A IN2014MN01806 A IN 2014MN01806A IN 1806MUN2014 A IN1806MUN2014 A IN 1806MUN2014A IN 2014MN01806 A IN2014MN01806 A IN 2014MN01806A
- Authority
- IN
- India
- Prior art keywords
- gcd
- glucocerecbrosidase
- disease
- comprised
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Physics & Mathematics (AREA)
- Physiology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600651P | 2012-02-19 | 2012-02-19 | |
| US201261736059P | 2012-12-12 | 2012-12-12 | |
| PCT/IB2013/051346 WO2013121405A1 (fr) | 2012-02-19 | 2013-02-19 | Formes galéniques unitaires administrées par voie orale et utilisations de celles-ci pour le traitement de la maladie de gaucher |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01806A true IN2014MN01806A (fr) | 2015-07-03 |
Family
ID=48040380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1806MUN2014 IN2014MN01806A (fr) | 2012-02-19 | 2013-02-19 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150023929A1 (fr) |
| EP (1) | EP2814838A1 (fr) |
| KR (1) | KR20140130495A (fr) |
| CN (1) | CN104245725A (fr) |
| AU (1) | AU2013220005A1 (fr) |
| BR (1) | BR112014021067A2 (fr) |
| CA (1) | CA2863829A1 (fr) |
| IL (1) | IL234093A0 (fr) |
| IN (1) | IN2014MN01806A (fr) |
| RU (1) | RU2014137404A (fr) |
| WO (1) | WO2013121405A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170101633A1 (en) | 2014-02-10 | 2017-04-13 | Protalix Ltd. | Method of maintaining disease stability in a subject having gaucher's disease |
| CN106170402B (zh) * | 2014-04-10 | 2018-09-21 | 米其林企业总公司 | 轮胎胎面和轮胎 |
| EP3692075A4 (fr) * | 2017-10-03 | 2022-02-09 | Prevail Therapeutics, Inc. | Thérapies géniques pour troubles lysosomaux |
| WO2019231725A2 (fr) * | 2018-05-27 | 2019-12-05 | Bioasis Technolgies Inc. | Traitement de la maladie de gaucher |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| CA1192510A (fr) | 1981-05-27 | 1985-08-27 | Lawrence E. Pelcher | Vecteur de arn virale de virus des plantes ou portion de ce vecteur, methode de construction, et methode de production d'un gene derive |
| US4588693A (en) | 1983-02-28 | 1986-05-13 | Research And Development Institute, Inc. At Montana State University | Development of plant roots |
| JPS6054684A (ja) | 1983-09-05 | 1985-03-29 | Teijin Ltd | 新規ｄνａ及びハイブリツドｄνａ |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| CA1288073C (fr) | 1985-03-07 | 1991-08-27 | Paul G. Ahlquist | Vecteur de transformation de l'arn |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| GB8608850D0 (en) | 1986-04-11 | 1986-05-14 | Diatech Ltd | Packaging system |
| JPS6314693A (ja) | 1986-07-04 | 1988-01-21 | Sumitomo Chem Co Ltd | 植物ウイルスｒｎａベクタ− |
| ATE108828T1 (de) | 1987-02-09 | 1994-08-15 | Lubrizol Genetics Inc | Hybrides rns-virus. |
| US5316931A (en) | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
| US5693507A (en) | 1988-09-26 | 1997-12-02 | Auburn University | Genetic engineering of plant chloroplasts |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5302523A (en) | 1989-06-21 | 1994-04-12 | Zeneca Limited | Transformation of plant cells |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| UA48104C2 (uk) | 1991-10-04 | 2002-08-15 | Новартіс Аг | Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| AU6504796A (en) | 1995-07-20 | 1997-02-18 | Washington State University Research Foundation | Production of secreted foreign polypeptides in plant cell culture |
| IL155588A0 (en) | 2003-04-27 | 2003-11-23 | Metabogal Ltd | Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby |
| IL119310A (en) | 1996-09-26 | 1999-07-14 | Metabogal Ltd | Cell/tissue culturing device and method |
| KR100266448B1 (ko) | 1997-06-26 | 2000-09-15 | 박종헌 | 식물세포 배양 중의 온도변화에 의한 택솔의 대량생산 방법 |
| US7951557B2 (en) * | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
| WO2007010533A2 (fr) * | 2005-07-18 | 2007-01-25 | Protalix Ltd. | Administration mucosale ou enterale de macromolecules biologiquement actives |
| CA2685701C (fr) | 2007-05-07 | 2019-01-15 | Protalix Ltd. | Bioreacteur jetable a grande echelle |
| US9024110B2 (en) * | 2010-03-23 | 2015-05-05 | Zhang Yang | Methods for glyco-engineering plant cells for controlled human O-glycosylation |
-
2013
- 2013-02-19 RU RU2014137404A patent/RU2014137404A/ru unknown
- 2013-02-19 CN CN201380020238.4A patent/CN104245725A/zh active Pending
- 2013-02-19 IN IN1806MUN2014 patent/IN2014MN01806A/en unknown
- 2013-02-19 WO PCT/IB2013/051346 patent/WO2013121405A1/fr active Application Filing
- 2013-02-19 KR KR20147026336A patent/KR20140130495A/ko not_active Application Discontinuation
- 2013-02-19 BR BR112014021067A patent/BR112014021067A2/pt not_active IP Right Cessation
- 2013-02-19 CA CA2863829A patent/CA2863829A1/fr not_active Abandoned
- 2013-02-19 EP EP13713245.2A patent/EP2814838A1/fr not_active Withdrawn
- 2013-02-19 AU AU2013220005A patent/AU2013220005A1/en not_active Abandoned
- 2013-02-19 US US14/379,547 patent/US20150023929A1/en not_active Abandoned
-
2014
- 2014-08-13 IL IL234093A patent/IL234093A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2814838A1 (fr) | 2014-12-24 |
| IL234093A0 (en) | 2014-09-30 |
| AU2013220005A1 (en) | 2014-09-04 |
| KR20140130495A (ko) | 2014-11-10 |
| BR112014021067A2 (pt) | 2018-10-30 |
| US20150023929A1 (en) | 2015-01-22 |
| WO2013121405A1 (fr) | 2013-08-22 |
| CA2863829A1 (fr) | 2013-08-22 |
| RU2014137404A (ru) | 2016-04-10 |
| CN104245725A (zh) | 2014-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN06720A (fr) | ||
| PH12015500301B1 (en) | A novel formulation of diclofenac | |
| MX2012007977A (es) | Metodo para tratar condiciones neurologicas con glicocidos cardiacos. | |
| PE20151727A1 (es) | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c | |
| MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
| TN2011000544A1 (en) | A novel formualtion of indomethacin | |
| MX370543B (es) | Profarmacos neutralizantes del factor de crecimiento endotelial vascular para el tratamiento de afecciones oculares. | |
| MD20140059A2 (en) | Substituted 4-phenyl-pyridines for the treatment of NK-1 receptor related diseases | |
| PH12016500746B1 (en) | A novel formulation of meloxicam | |
| MX360019B (es) | Una formulación novedosa de metaxalona. | |
| TN2011000536A1 (en) | A novel formulation of naproxen | |
| EP2582682A4 (fr) | Procédés pour traiter une affection pulmonaire | |
| MX350666B (es) | Composiciones y sus usos para tratar hiperuricemia y trastornos metabolicos asociados con hiperuricemia. | |
| MX2014002394A (es) | Inhibidores de rock suaves, novedosos. | |
| IN2014MN02269A (fr) | ||
| MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| IN2014MN01806A (fr) | ||
| MX356317B (es) | Tratamiento de síntomas asociados a gastroparesia femenina. | |
| IN2014CN02332A (fr) | ||
| NZ629964A (en) | Method for treating inflammation | |
| NZ630125A (en) | Herbal composition for the treatment of metabolic disorders | |
| MX2014000870A (es) | Composiciones farmaceuticas que comprenden 4-bromo-n-(imidazolidin -2-iliden)-1h-benzimidazol-5-amina para tratar enfermedades de la retina. | |
| MX2015016678A (es) | Formulaciones farmaceuticas que comprenden agomelatina en forma de cocristal de agomelatina con un acido organico. | |
| UA53217U (en) | Mask for therapy and general health improvement | |
| UA61670U (ru) | Способ лечения тревожно-депрессивных расстройств, обусловленных соматической патологией |